TY - JOUR
T1 - Multiple cardiovascular risk factor care in 55 low- and middle-income countries
T2 - A cross-sectional analysis of nationally-representative, individual-level data from 280,783 adults
AU - Diallo, Alpha Oumar
AU - Marcus, Maja E.
AU - Flood, David
AU - Theilmann, Michaela
AU - Rahim, Nicholas E.
AU - Kinlaw, Alan
AU - Franceschini, Nora
AU - Stürmer, Til
AU - Tien, Dessie V.
AU - Abbasi-Kangevari, Mohsen
AU - Agoudavi, Kokou
AU - Andall-Brereton, Glennis
AU - Aryal, Krishna
AU - Bahendeka, Silver
AU - Brice, Bicaba
AU - Bovet, Pascal
AU - Dorobantu, Maria
AU - Farzadfar, Farshad
AU - Ghamari, Seyyed-Hadi
AU - Gathecha, Gladwell
AU - Guwatudde, David
AU - Gurung, Mongal
AU - Houehanou, Corine
AU - Houinato, Dismand
AU - Hwalla, Nahla
AU - Jorgensen, Jutta
AU - Kagaruki, Gibson
AU - Karki, Khem
AU - Martins, Joao
AU - Mayige, Mary
AU - McClure, Roy Wong
AU - Moghaddam, Sahar Saeedi
AU - Mwalim, Omar
AU - Mwangi, Joseph Kibachio
AU - Norov, Bolormaa
AU - Quesnel-Crooks, Sarah
AU - Sibai, Abla
AU - Sturua, Lela
AU - Tsabedze, Lindiwe
AU - Wesseh, Chea
AU - Geldsetzer, Pascal
AU - Atun, Rifat
AU - Vollmer, Sebastian
AU - Bärnighausen, Till
AU - Davies, Justine
AU - Ali, Mohammed K
AU - Seiglie , Jacqueline A.
AU - Gower, Emily W.
AU - Manne-Goehler, Jennifer
N1 - Funding:
Harvard T H Chan School of Public Health McLennan Fund: Dean's Challenge Grant Program and the EU's Research and Innovation programme Horizon 2020. There are no grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
PY - 2024/3/27
Y1 - 2024/3/27
N2 - The prevalence of multiple age-related cardiovascular disease (CVD) risk factors is high among individuals living in low- and middle-income countries. We described receipt of healthcare services for and management of hypertension and diabetes among individuals living with these conditions using individual-level data from 55 nationally representative population-based surveys (2009–2019) with measured blood pressure (BP) and diabetes biomarker. We restricted our analysis to non-pregnant individuals aged 40–69 years and defined three mutually exclusive groups (i.e., hypertension only, diabetes only, and both hypertension-diabetes) to compare individuals living with concurrent hypertension and diabetes to individuals with each condition separately. We included 90,086 individuals who lived with hypertension only, 11,975 with diabetes only, and 16,228 with hypertension-diabetes. We estimated the percentage of individuals who were aware of their diagnosis, used pharmacological therapy, or achieved appropriate hypertension and diabetes management. A greater percentage of individuals with hypertension-diabetes were fully diagnosed (64.1% [95% CI: 61.8–66.4]) than those with hypertension only (47.4% [45.3–49.6]) or diabetes only (46.7% [44.1–49.2]). Among the hypertension-diabetes group, pharmacological treatment was higher for individual conditions (38.3% [95% CI: 34.8–41.8] using antihypertensive and 42.3% [95% CI: 39.4–45.2] using glucose-lowering medications) than for both conditions jointly (24.6% [95% CI: 22.1–27.2]).The percentage of individuals achieving appropriate management was highest in the hypertension group (17.6% [16.4–18.8]), followed by diabetes (13.3% [10.7–15.8]) and hypertension-diabetes (6.6% [5.4–7.8]) groups. Although health systems in LMICs are reaching a larger share of individuals living with both hypertension and diabetes than those living with just one of these conditions, only seven percent achieved both BP and blood glucose treatment targets. Implementation of cost-effective population-level interventions that shift clinical care paradigm from disease-specific to comprehensive CVD care are urgently needed for all three groups, especially for those with multiple CVD risk factors.
AB - The prevalence of multiple age-related cardiovascular disease (CVD) risk factors is high among individuals living in low- and middle-income countries. We described receipt of healthcare services for and management of hypertension and diabetes among individuals living with these conditions using individual-level data from 55 nationally representative population-based surveys (2009–2019) with measured blood pressure (BP) and diabetes biomarker. We restricted our analysis to non-pregnant individuals aged 40–69 years and defined three mutually exclusive groups (i.e., hypertension only, diabetes only, and both hypertension-diabetes) to compare individuals living with concurrent hypertension and diabetes to individuals with each condition separately. We included 90,086 individuals who lived with hypertension only, 11,975 with diabetes only, and 16,228 with hypertension-diabetes. We estimated the percentage of individuals who were aware of their diagnosis, used pharmacological therapy, or achieved appropriate hypertension and diabetes management. A greater percentage of individuals with hypertension-diabetes were fully diagnosed (64.1% [95% CI: 61.8–66.4]) than those with hypertension only (47.4% [45.3–49.6]) or diabetes only (46.7% [44.1–49.2]). Among the hypertension-diabetes group, pharmacological treatment was higher for individual conditions (38.3% [95% CI: 34.8–41.8] using antihypertensive and 42.3% [95% CI: 39.4–45.2] using glucose-lowering medications) than for both conditions jointly (24.6% [95% CI: 22.1–27.2]).The percentage of individuals achieving appropriate management was highest in the hypertension group (17.6% [16.4–18.8]), followed by diabetes (13.3% [10.7–15.8]) and hypertension-diabetes (6.6% [5.4–7.8]) groups. Although health systems in LMICs are reaching a larger share of individuals living with both hypertension and diabetes than those living with just one of these conditions, only seven percent achieved both BP and blood glucose treatment targets. Implementation of cost-effective population-level interventions that shift clinical care paradigm from disease-specific to comprehensive CVD care are urgently needed for all three groups, especially for those with multiple CVD risk factors.
UR - https://journals.plos.org/globalpublichealth/
U2 - 10.1371/journal.pgph.0003019
DO - 10.1371/journal.pgph.0003019
M3 - Article
SN - 2767-3375
VL - 4
JO - PLOS Global Public Health
JF - PLOS Global Public Health
IS - 3
M1 - e0003019
ER -